View ValuationVoronoi 将来の成長Future 基準チェック /26Voronoiの収益は年間14.8%で減少すると予測されていますが、年間収益は年間39.2%で増加すると予測されています。EPS は年間 減少すると予測されています。自己資本利益率は 3 年後に-114.6% 14.3%なると予測されています。主要情報-14.8%収益成長率-14.34%EPS成長率Biotechs 収益成長37.2%収益成長率39.2%将来の株主資本利益率-114.60%アナリストカバレッジLow最終更新日19 Apr 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • Mar 14New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₩7.5b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (₩55b net loss in 2 years). Share price has been volatile over the past 3 months (13% average weekly change). Revenue is less than US$5m (₩7.5b revenue, or US$5.0m).お知らせ • Mar 14Voronoi, Inc., Annual General Meeting, Mar 30, 2026Voronoi, Inc., Annual General Meeting, Mar 30, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 32, songdogwahak-ro, yeonsu-gu, incheon South Korea分析記事 • Apr 25Voronoi (KOSDAQ:310210) Is In A Good Position To Deliver On Growth PlansWe can readily understand why investors are attracted to unprofitable companies. Indeed, Voronoi ( KOSDAQ:310210...New Risk • Apr 21New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 32% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings are forecast to decline by an average of 32% per year for the foreseeable future. Revenue is less than US$1m. Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (₩102b net loss in 3 years).お知らせ • Mar 13Voronoi, Inc., Annual General Meeting, Mar 28, 2025Voronoi, Inc., Annual General Meeting, Mar 28, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 32, songdogwahak-ro, yeonsu-gu, incheon South KoreaNew Risk • Feb 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue is less than US$1m. Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (₩37b net loss in 2 years).分析記事 • Jan 03Voronoi (KOSDAQ:310210) Is In A Good Position To Deliver On Growth PlansEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...New Risk • Nov 21New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.7% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings are forecast to decline by an average of 0.7% per year for the foreseeable future. Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (₩35b net loss in 2 years). Shareholders have been diluted in the past year (6.1% increase in shares outstanding).分析記事 • Sep 20Health Check: How Prudently Does Voronoi (KOSDAQ:310210) Use Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings are forecast to decline by an average of 1.8% per year for the foreseeable future. Minor Risk Shareholders have been diluted in the past year (41% increase in shares outstanding).New Risk • Aug 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (₩32b net loss in 2 years). Shareholders have been diluted in the past year (20% increase in shares outstanding).New Risk • Jun 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (₩32b net loss in 2 years). Share price has been volatile over the past 3 months (7.5% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding).分析記事 • May 28Is Voronoi (KOSDAQ:310210) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Nov 19Third quarter 2023 earnings released: ₩437 loss per share (vs ₩109 profit in 3Q 2022)Third quarter 2023 results: ₩437 loss per share (down from ₩109 profit in 3Q 2022). Net loss: ₩6.62b (down ₩8.11b from profit in 3Q 2022). Revenue is forecast to grow 108% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Biotechs industry in South Korea.New Risk • Oct 06New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings are forecast to decline by an average of 10% per year for the foreseeable future. Minor Risks Less than 3 years of financial data is available. Currently unprofitable and not forecast to become profitable over next 2 years (₩30b net loss in 2 years). Shareholders have been diluted in the past year (13% increase in shares outstanding).お知らせ • Sep 07Voronoi, Inc. has completed a Follow-on Equity Offering in the amount of KRW 61.28976 billion.Voronoi, Inc. has completed a Follow-on Equity Offering in the amount of KRW 61.28976 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,287,600 Price\Range: KRW 47600 Discount Per Security: KRW 665.6 Transaction Features: Rights OfferingNew Risk • Sep 01New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩20b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings are forecast to decline by an average of 10% per year for the foreseeable future. Minor Risks Less than 3 years of financial data is available. Currently unprofitable and not forecast to become profitable over next 2 years (₩30b net loss in 2 years).業績と収益の成長予測KOSDAQ:A310210 - アナリストの将来予測と過去の財務データ ( )KRW Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202851,000-76,000-101,000-101,000112/31/202725,367-51,800-39,600-43,933312/31/202634,000-48,933-71,000-71,000112/31/20257,512-42,706-73,777-72,095N/A9/30/20257,490-47,263-47,147-45,007N/A6/30/20253,350-42,895-41,459-39,408N/A3/31/2025N/A-40,152-37,568-35,555N/A12/31/2024N/A-32,613-30,284-29,052N/A9/30/2024N/A-38,879-30,330-29,615N/A6/30/2024N/A-36,066-28,095-27,210N/A3/31/2024N/A-35,040-27,951-27,098N/A12/31/2023N/A-36,848-29,931-28,849N/A9/30/2023589-30,991-27,157-26,022N/A6/30/20237,943-22,876-19,738-18,876N/A3/31/20238,630-22,143-17,500-16,744N/A12/31/20229,768-19,900-16,887-16,335N/A9/30/202213,845-14,095-12,843-12,558N/A6/30/202212,167-18,108-19,806-19,568N/A3/31/202214,419-18,833-17,044-16,740N/A12/31/202114,784-15,096-18,223-17,640N/A9/30/202116,095-12,472-15,420-14,940N/A12/31/20206,180-23,187-16,272-15,895N/A12/31/2019301-50,003-39,323-33,634N/A12/31/2018174-9,218N/A-9,371N/A12/31/201734-1,882N/A-2,280N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: A310210今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: A310210今後 3 年間、利益が出ない状態が続くと予測されています。高成長収益: A310210今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: A310210の収益 ( 39.2% ) KR市場 ( 16.5% ) よりも速いペースで成長すると予測されています。高い収益成長: A310210の収益 ( 39.2% ) 20%よりも速いペースで成長すると予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: A310210 3 年以内に赤字になると予測されています。成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 21:12終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Voronoi, Inc. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Heeyoung LeeDaishin Securities Co. Ltd.Ho-cheol LeeShinhan Investment Corp.Hyun-soo HaYuanta Securities Korea Co., Ltd.1 その他のアナリストを表示
New Risk • Mar 14New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₩7.5b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (₩55b net loss in 2 years). Share price has been volatile over the past 3 months (13% average weekly change). Revenue is less than US$5m (₩7.5b revenue, or US$5.0m).
お知らせ • Mar 14Voronoi, Inc., Annual General Meeting, Mar 30, 2026Voronoi, Inc., Annual General Meeting, Mar 30, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 32, songdogwahak-ro, yeonsu-gu, incheon South Korea
分析記事 • Apr 25Voronoi (KOSDAQ:310210) Is In A Good Position To Deliver On Growth PlansWe can readily understand why investors are attracted to unprofitable companies. Indeed, Voronoi ( KOSDAQ:310210...
New Risk • Apr 21New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 32% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings are forecast to decline by an average of 32% per year for the foreseeable future. Revenue is less than US$1m. Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (₩102b net loss in 3 years).
お知らせ • Mar 13Voronoi, Inc., Annual General Meeting, Mar 28, 2025Voronoi, Inc., Annual General Meeting, Mar 28, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 32, songdogwahak-ro, yeonsu-gu, incheon South Korea
New Risk • Feb 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue is less than US$1m. Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (₩37b net loss in 2 years).
分析記事 • Jan 03Voronoi (KOSDAQ:310210) Is In A Good Position To Deliver On Growth PlansEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
New Risk • Nov 21New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.7% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings are forecast to decline by an average of 0.7% per year for the foreseeable future. Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (₩35b net loss in 2 years). Shareholders have been diluted in the past year (6.1% increase in shares outstanding).
分析記事 • Sep 20Health Check: How Prudently Does Voronoi (KOSDAQ:310210) Use Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings are forecast to decline by an average of 1.8% per year for the foreseeable future. Minor Risk Shareholders have been diluted in the past year (41% increase in shares outstanding).
New Risk • Aug 05New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (₩32b net loss in 2 years). Shareholders have been diluted in the past year (20% increase in shares outstanding).
New Risk • Jun 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (₩32b net loss in 2 years). Share price has been volatile over the past 3 months (7.5% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding).
分析記事 • May 28Is Voronoi (KOSDAQ:310210) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Nov 19Third quarter 2023 earnings released: ₩437 loss per share (vs ₩109 profit in 3Q 2022)Third quarter 2023 results: ₩437 loss per share (down from ₩109 profit in 3Q 2022). Net loss: ₩6.62b (down ₩8.11b from profit in 3Q 2022). Revenue is forecast to grow 108% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Biotechs industry in South Korea.
New Risk • Oct 06New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings are forecast to decline by an average of 10% per year for the foreseeable future. Minor Risks Less than 3 years of financial data is available. Currently unprofitable and not forecast to become profitable over next 2 years (₩30b net loss in 2 years). Shareholders have been diluted in the past year (13% increase in shares outstanding).
お知らせ • Sep 07Voronoi, Inc. has completed a Follow-on Equity Offering in the amount of KRW 61.28976 billion.Voronoi, Inc. has completed a Follow-on Equity Offering in the amount of KRW 61.28976 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,287,600 Price\Range: KRW 47600 Discount Per Security: KRW 665.6 Transaction Features: Rights Offering
New Risk • Sep 01New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩20b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings are forecast to decline by an average of 10% per year for the foreseeable future. Minor Risks Less than 3 years of financial data is available. Currently unprofitable and not forecast to become profitable over next 2 years (₩30b net loss in 2 years).